Revenue
2011
2019
2020
2022
2023
2024
2025
Cocrystal Pharma, Inc. (COCP)
Price$1.13Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | $2.0M | $6.6M | — | — | — | — | — | — | — | $12.7M | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | $7.2M | $2.7M | $6.8M |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 21.13% | — |
| Research & development | $5.1M | $12.5M | $15.2M | $12.4M | $8.8M | $6.0M | $4.0M | $4.7M | $5.8M | $101.7M | $47.3M | $4.1M | $3.9M | $489,345 | $423,183 | $240,873 |
| Operating expenses | $9.0M | $17.9M | $18.6M | $38.8M | $14.2M | $11.6M | $55.0M | $62.9M | $8.3M | $105.8M | $54.0M | $5.8M | $4.1M | $2.6M | $6.6M | $6.9M |
| Operating income | −$9.0M | −$17.9M | −$18.6M | −$38.8M | −$14.2M | −$9.6M | −$48.4M | −$62.9M | −$8.3M | −$105.8M | −$53.9M | −$5.8M | −$4.1M | −$2.6M | −$3.9M | −$32,045 |
| Operating margin | — | — | — | — | — | −475.97% | −737.45% | — | — | — | — | — | — | — | −30.58% | — |
| EBITDA | −$8.9M | −$17.8M | −$18.4M | −$38.6M | −$14.0M | −$9.4M | −$48.3M | −$62.9M | −$8.2M | −$105.6M | −$53.8M | −$5.6M | −$3.8M | −$2.4M | −$3.4M | $400,521 |
| EBITDA margin | — | — | — | — | — | −468.17% | −735.95% | — | — | — | — | — | — | — | −26.39% | — |
| Net income | −$8.8M | −$17.5M | −$18.0M | −$38.8M | −$14.2M | −$9.6M | −$48.2M | −$49.0M | −$613,000 | −$74.9M | −$50.1M | −$99,000 | −$3.9M | −$8.0M | −$5.5M | −$319,813 |
| Net profit margin | — | — | — | — | — | −479.05% | −733.84% | — | — | — | — | — | — | — | −42.93% | — |
| Basic EPSper basic share | -$0.78 | -$1.72 | -$1.87 | -$4.77 | -$0.16 | -$2.04 | -$18.12 | -$21.00 | -$0.36 | -$38.16 | -$28.80 | $0.00 | -$25.20 | -$46.80 | -$39.60 | -$3.60 |
| Diluted EPSper diluted share | -$0.78 | -$1.72 | -$1.87 | -$4.77 | -$1.92 | -$2.04 | -$18.12 | -$21.00 | -$0.36 | -$39.60 | -$28.80 | -$3.60 | -$25.20 | — | -$39.60 | — |
Owners
Reported shareholders
≈19.29%of listed shares
Rubin Steven D2.66M shares · Oct 9, 2024
View holders
| Holder | % owned |
|---|---|
Rubin Steven D | ≈19.29%2.66M shares |
FROST PHILLIP MD ET AL | ≈14.04%1.94M shares |
Hassan Fred | ≈10.03%1.38M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.60%358.23K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.30%179.63K shares |
TWO SIGMA INVESTMENTS, LP | 1.27%175.38K shares |
Lee Sam | ≈0.55%76.36K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.55%76.21K shares |
BlackRock, Inc. | 0.53%73.75K shares |
Kornberg Roger D. | ≈0.49%67.88K shares |
CITADEL ADVISORS LLC | 0.33%45.12K shares |
Martin James Joseph | ≈0.32%44.17K shares |
NEUBERGER BERMAN GROUP LLC | 0.23%31.89K shares |
PFENNIGER RICHARD C JR | ≈0.23%31.4K shares |
XTX Topco Ltd | 0.21%29.34K shares |
JANE STREET GROUP, LLC | 0.19%25.76K shares |
VANGUARD FIDUCIARY TRUST CO | 0.17%24.02K shares |
STATE STREET CORP | 0.15%20.54K shares |
HRT FINANCIAL LP | 0.15%20.34K shares |
Japour Anthony J | ≈0.11%14.92K shares |
Percentages use 13.79M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 24, 2026Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 20.0K | $1.00 | $20.0K | 1.91M |
| Feb 6, 2026Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 50.0K | $0.95 | $47.5K | 1.89M |
| Dec 31, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 50.0K | $0.95 | $47.5K | 1.84M |
| Dec 30, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 20.0K | $0.97 | $19.4K | 1.79M |
| Dec 26, 2025Form 4 | FROST PHILLIP MD ET ALDirector,TenPercentOwner | BuyCommon Stock · indirect | 40.0K | $0.97 | $38.8K | 1.77M |